---
title: Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial
date: '2024-12-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39665649/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241212174419&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: In this trial involving patients with clinically node-negative,
  T1 or T2 invasive breast cancer (90% with clinical T1 cancer and 79% with pathological
  T1 cancer), omission of surgical axillary staging was noninferior to sentinel-lymph-node
  biopsy after a median follow-up of 6 years. (Funded by the German Cancer Aid; INSEMA
  ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: In this trial involving patients with clinically node-negative, T1 or T2 invasive breast cancer (90% with clinical T1 cancer and 79% with pathological T1 cancer), omission of surgical axillary staging was noninferior to sentinel-lymph-node biopsy after a median follow-up of 6 years. (Funded by the German Cancer Aid; INSEMA ClinicalTrials.gov number, ...